Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02561221 · ClinicalTrials.gov registry record · NA

Promoting Successful Weight Loss in Primary Care in Louisiana

A NA study of Obesity, sponsored by Pennington Biomedical Research Center.

Completed
Registry status
NA
Development phase
803
Enrollment target
1
Study location

NCT02561221: Completed NA study of Obesity, sponsored by Pennington Biomedical Research Center.

NCT02561221 is a NA study of Obesity that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 803 participants, roughly in line with the 818-participant average among 1,053 other Obesity trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02561221, a NA study of Obesity, has completed, sponsored by Pennington Biomedical Research Center.

COMPLETED
Registry status
NA
Development phase
803 participants
Enrollment target
1
Study location

Study Summary

The primary aim of this trial is to develop and test the effectiveness of a 24 month, patient-centered, pragmatic and scalable obesity treatment program delivered within primary care, inclusive of an underserved population. Half of the clinics received a behavioral intervention delivered in a primary care setting and half of the clinics received usual care.

Primary Outcome

Body weight is measured in light indoor clothes.

Conditions Studied

Interventions

  • BEHAVIORAL Lifestyle Counseling

Study Locations (1)

Louisiana

  • Pennington Biomedical Research Center - Baton Rouge

Trial Details

FieldValue
Enrollment Target 803 participants
Start Date 2016-04
Est. Completion 2019-09-06
Phase NA

What the finished NCT02561221 record still lists

NCT02561221 is an interventional study that assigns participants to a tested intervention. The registered 803 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 818-participant average among 1,053 other Obesity trials with a reported enrollment target.

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Lifestyle Counseling is the first listed.

NCT02561221 reports a single indexed study location in Louisiana.

Frequently Asked Questions

What is clinical trial NCT02561221 about?

NCT02561221 is a clinical study titled "Promoting Successful Weight Loss in Primary Care in Louisiana". The primary aim of this trial is to develop and test the effectiveness of a 24 month, patient-centered, pragmatic and scalable obesity treatment program delivered within primary care, inclusive of an underserved population. Half of the clinics received a behavioral intervention delivered in a primar...

What is the current status of trial NCT02561221?

This trial is currently completed. It is a NA study. The enrollment target is 803 participants. The study started on 2016-04. Estimated completion is 2019-09-06.

What conditions does trial NCT02561221 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT02561221?

The interventions under investigation include: Lifestyle Counseling (BEHAVIORAL).

Who is sponsoring clinical trial NCT02561221?

This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02561221 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02561221's enrollment target sits among peer trials

803 90th of 1053 higher than 964 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04423211 · 804 participants · Phase 3

    Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

  • NCT06522022 · 804 participants · NA

    PTSD Screening in Pregnant Black Women

  • NCT03524430 · 801 participants · NA

    RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy

  • NCT04613596 · 806 participants · Phase 2

    Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02561221, the US trial registry maintained by the National Library of Medicine. NCT02561221 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.